Warfarin treatment outcomes in children monitored at home with a point-of-care device

Tina T. Biss; Peter J. Avery; Patricia M. Walsh; Farhad Kamali

doi:10.1160/TH10-09-0608

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2011; 105(06): 1103-1105
DOI: 10.1160/TH10-09-0608

Letters to the Editor

Schattauer GmbH

Warfarin treatment outcomes in children monitored at home with a point-of-care device

Authors

Tina T. Biss

¹Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK
Peter J. Avery

²School of Mathematics and Statistics, Newcastle University, Newcastle upon Tyne, UK
Patricia M. Walsh

³Department of Paediatric Cardiology, The Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK
Farhad Kamali

¹Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK

Abstract

Full Text

References

References
1 Streif W, Andrew M, Marzinotto V. et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood 1999; 94: 3007-3014.
2 Black KL, Bauman ME, Kuhle S. et al. Warfarin therapy induced coagulopathy in children: assessment of a conservative approach. J Thromb Haemost. 2009 7 (Suppl1): OC-TU-066 (Abstract).
3 Massicotte P, Julian JA, Gent M. et al. An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial. Thromb Res 2003; 109: 85-92.
4 Newall F, Campbell J, Savoia H. et al. Incidence of major bleeding in a large paediatric cohort of patients requiring warfarin therapy. J Thromb Haemost. 2005 3 (Suppl1): OR357 (Abstract).
5 Newall F, Savoia H, Campbell J. et al. Anticoagulation clinics for children achieve improved warfarin management. Thromb Res 2004; 114: 5-9.
6 Bradbury MJ, Taylor G, Short P. et al. A comparative study of anticoagulant control in patients on long-term warfarin using home and hospital monitoring of the international normalised ratio. Arch Dis Child 2008; 93: 303-306.
7 Newall F, Monagle P, Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the Coaguchek^TM S point-of-care monitor and a robust education program. Thromb Res 2006; 118: 587-593.
8 Bhat D, Upponi A, Rakecha A. et al. Evaluating safety, effectiveness, and user satisfaction of home international normalized ratio monitoring service: Experience from a tertiary pediatric cardiology unit in the United Kingdom. Pediatr Cardiol 2010; 31: 18-21.
9 Bauman ME, Black KL, Massicotte MP. et al. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb Haemost 2008; 99: 1097-1103.
10 Marzinotto V, Monagle P, Chan A. et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 2000; 21: 347-352.
11 Greenway A, Ignjatovic V, Summerhayes R. et al. Point-of-care monitoring of oral anticoagulant therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95). Thromb Haemost 2009; 102: 159-165.
12 Bauman ME, Black K, Kuhle S. KIDCLOT©: The importance of validated educational intervention for optimal long term warfarin management in children. Thromb Res 2009; 123: 707-709.